Litecoin Could See ETFs Before Solana & XRP – As Sui and Remittix Tipped For Huge Gains In 2025
IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out
IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out
IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.
